ECOncrete: Funding, Investors & Team (Sep 2026)
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures, in the coastal and marine environment as well as other urban landscapes. The Company develops, produces and supports implementation of innovative concrete products designed for enhancing the biological and ecological value of coastal and marine infrastructures. ECOncrete's unique biological traits encourage biogenic buildup. They also provide substantial structural and economic advantages in terms of increased stability and longevity, as well as a reduction in maintenance costs.
ECOncrete has raised $19.0M across 2 funding rounds on record, the most recent an undisclosed round of $14.0M announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ECOncrete Company Profile and Key Stats
Latest funding round on record: May 2026.
ECOncrete Funding Rounds
ECOncrete raised $5.0M in an undisclosed round announced in Jun 2020.
5.9 years later, an undisclosed round of $14.0M was announced in May 2026.
ECOncrete Founders and Leadership Team
Contact details for the ECOncrete team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →ECOncrete Funding Compared to Other Biotechnology Startups
ECOncrete's latest round of $14.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ECOncrete in Biotechnology and Tel Aviv
Companies Similar to ECOncrete
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
NeuroSense Therapeutics Ltd., is a clinical-stage biotechnology company, dedicated to the discovery and…
ECOncrete Funding FAQs
What does ECOncrete do?
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures, in the coastal and marine environment as well as other urban landscapes. The Company develops, produces and supports implementation of innovative concrete products designed for enhancing the biological and ecological value of coastal and marine infrastructures. ECOncrete's unique biological traits encourage biogenic buildup. They also provide substantial structural and economic advantages in terms of increased stability and longevity, as well as a reduction in maintenance costs.
How much funding has ECOncrete raised?
ECOncrete has raised $19.0M across 2 rounds on record. The most recent is an undisclosed round of $14.0M announced in May 2026.
When did ECOncrete last raise funding?
ECOncrete's most recent funding round on record is an undisclosed round of $14.0M, announced in May 2026.
Who founded ECOncrete?
FundedIQ lists Ido Sella (Founder) at ECOncrete.
Who is the CEO of ECOncrete?
Shimrit Perkol-Finkel is listed as CEO at ECOncrete.
Where is ECOncrete headquartered?
ECOncrete is based in Tel Aviv, Israel.
How many employees does ECOncrete have?
ECOncrete is in the 11-50 employee band.
How does ECOncrete's funding compare to other Biotechnology startups?
ECOncrete's latest round of $14.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ECOncrete Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ECOncrete is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.